Mistura Viva

Viva Biotech provides comprehensive contract research and development services from early-stage structure-based drug discovery to commercial manufacturing. The company serves global biotech and pharma clients with expertise in protein expression/structure determination, hit screening, lead optimization, medicinal chemistry, antibody discovery/production, bioassays, ADME/PK studies. It also invests in early-stage biotech startups via an equity-for-service model.[1][2][3] Recent financials show strong growth with revenue reaching RMB 1.99 billion (~$275M USD) in 2024.[9] The company has incubated/invested in over 56 startups as of mid–2020.[5] In May 2025 it launched an AI-driven drug discovery platform.[3]